Worldwide, there are more than 20 million new cases of cancer each year. First-line therapies are not always the most effective and there is a strong need to move towards personalized medicine by offering the patients the best treatment as quickly as possible. This will help in increasing the chance or cure. Therefore, there is a need to improve the prediction of the response to treatments to be able to save patient’s lives and reduce the cost of expensive inefficient treatments. Our goal is to unlock the road to precision medicine by using multiomics, spatial data and AI.
| Website | https://rosetta-omics.com/ |
| Employees | 15 (2 on RocketReach) |
| Founded | 2022 |
| Industry | Biotechnology Research |
| Keywords | Personalized Medicine, Precision Oncology, Oncology Research, Cancer Diagnostics, Cancer Research, Cancer Treatment, Genomic Testing, Biomarker Discovery, Molecular Diagnostics, Genetic Testing, Next Generation Sequencing, Disease Diagnostics, Liquid Biopsy, Drug Development, Dna Sequencing, Proteomics, Ngs, Clinical Trials, Rna Sequencing |
| Competitors | Thermo Fisher Scientific, Mayo Clinic Laboratories, Guardant Health, GeneDx, NantHealth, 23andMe, PathAI, Genomic Health, CureMetrix, biocrates life sciences ag +45 more (view full list) |
Looking for a particular Rosetta Omics employee's phone or email?
Rosetta Omics Questions
Wahid Awad is the Founder and Chief Executive Officer of Rosetta Omics.
2 people are employed at Rosetta Omics.
Rosetta Omics is based in Paris, Île-de-France.
Top Rosetta Omics Employees
